Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (8,306) $ (9,785)
Stock option compensation to employees and directors 2,822 3,440
Stock options issued to consultants 77 101
Common stock issued to consultants 255
Amortization of operating lease right-of-use asset 27 28
Amortization of discount on held-to-maturity securities (93)
Change in operating assets and liabilities:    
Receivables 173 (140)
Prepaid expenses and other current assets (155) (273)
Accounts payable (249) 96
Accrued expenses (195) (92)
Operating lease liability (19) (38)
Net cash used in operating activities (5,918) (6,408)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (36,700) (47,307)
Proceeds from maturities of short-term investments 40,912 50,716
Net cash provided by investing activities 4,212 3,409
Cash flows from financing activities:    
Proceeds from sale of common stock in an at-the-market offering, net of offering expenses of $123 and $139, respectively 1,924 2,984
Proceeds from sale of common stock pursuant to an employee stock purchase plan 4 7
Proceeds from exercise of stock options 2 318
Net cash provided by financing activities 1,930 3,309
Net increase in cash and cash equivalents 224 310
Cash and cash equivalents at beginning of period 1,271 915
Cash and cash equivalents at end of period 1,495 1,225
Supplemental disclosure of non-cash investing activity:    
Operating lease right-of-use asset from lease extension (100)
Supplemental disclosure of non-cash financing activity:    
Operating lease liability from lease extension $ 100